Portfolio Management interview preparation
Asset allocation, factor models, risk, attribution and implementation, on global and Indian portfolios. Every question is either traced to a named firm from a public candidate report, or tagged at desk level when we could not trace it, and answers lead with the point, then the mechanism, then the limitation.
100 questions, mapped to the firms that asked them
- Questions
- 100
- Traced to a firm
- 40
- Firms
- 24
- Updated
- September 2026
008If CAPM is right, why does the low-volatility anomaly exist?Factor investingQuantitative asset management
Say this
Because most investors cannot use leverage, so they buy high beta instead. That bids up risky stocks and leaves low beta ones cheap, which flattens the security market line and hands a risk-adjusted premium to whoever can lever a low-vol portfolio.
Then walk it
- The empirical fact first: portfolios of low volatility or low beta stocks have delivered similar or better absolute returns than high beta ones, with far lower risk, in most markets over long samples.
- Explanation one, leverage constraints. A long-only fund that needs 10 percent expected return cannot lever a defensive portfolio, so it buys high beta. Frazzini and Pedersen's betting-against-beta trade is exactly this: long low beta levered up, short high beta.
- Explanation two, benchmark-relative incentives. A manager judged against an index measures risk as tracking error, and holding low beta stocks in a rising market is career risk. So the natural buyer of defensives is absent.
- Explanation three, behavioural. Lottery preference. Retail flows chase high volatility, high attention names, which is a persistent bid on the expensive side of the trade.
- The catch for implementation: much of the apparent premium is a bet on interest rates and on the sector composition, because low-vol screens load on staples, utilities and quality. Unhedged, you own a duration proxy, which is why low-vol struggled in 2022.
- So I would run it sector-neutral and rate-aware, and I would size it knowing the premium is mostly risk reduction rather than higher absolute return. That is still a good trade for an investor who cares about drawdown.
Where candidates lose it
Describing the anomaly and stopping. The question asks why, and the answer the interviewer is listening for is leverage constraints plus benchmark-relative incentives. Also flag the hidden rates and sector exposure, because a candidate who thinks low-vol is free risk reduction has not looked at 2022.
Expect next
- How would you neutralise the sector exposure?
- Why did low volatility fail in 2022?
- Is this arbitraged away now that everyone knows about it?
009How would you define the quality factor, and why is it harder to pin down than value?Factor investingQuantitative asset management
Say this
Quality is a composite, usually profitability, stability and low leverage, sometimes with accruals and payout added. It is harder to pin down than value because there is no single accounting ratio that defines it, so every provider builds it differently and the definitions disagree.
Then walk it
- The most defensible single component is gross profitability, revenues minus cost of goods over assets, from Novy-Marx. It is the version with the strongest out-of-sample record and it is nearly orthogonal to value.
- A standard composite adds return on equity, earnings stability, low accruals, low financial leverage and low net issuance. AQR's quality-minus-junk uses profitability, growth, safety and payout.
- Why it is slippery: value has one axis, price relative to a fundamental. Quality has no price in it at all, it is a description of the business, so you can construct it a dozen ways and get low correlation between the versions.
- That creates a real problem for an allocator. Two quality ETFs can have a correlation of active returns below 0.6, so 'I have quality exposure' does not tell you what you own until you look at the definition.
- The economic case is that markets underprice persistence. High-return businesses fade more slowly than the market assumes. The counter-case is that quality is partly just the residual of a long bull market in growth names.
- The interaction that matters most: quality without a valuation constraint is how you end up paying 45 times earnings for consumer staples. Quality at a reasonable price, essentially profitability combined with value, is the more robust construction and it is what most serious factor books run.
Where candidates lose it
Giving one ratio, usually ROE, as the answer. ROE alone is leverage-contaminated, which is why safety and low leverage sit in the composite. The stronger answer names gross profitability specifically and then says the honest thing, that quality definitions disagree with each other.
Expect next
- Why is gross profitability preferred to net margin?
- How do you stop a quality screen becoming expensive growth?
- Would quality work in India, where promoter-held companies dominate?
010Explain how you would construct a factor, and then how you would optimise that construction.AQR Capital ManagementInvestment Research · New York · 2021
Say this
Build the raw signal first, rank the universe, neutralise the exposures you do not want, then form the long-short portfolio. Optimising it is mostly about the same premium surviving costs: slower rebalancing, buffer zones, better weighting and trading the cheap end of the signal.
Then walk it
- Start with signal hygiene: point-in-time data with no look-ahead, lagged fundamentals by the real reporting delay, winsorise outliers, and standardise to z-scores within the universe.
- Neutralise deliberately. Sector, country, size and beta neutrality strip out exposures you are not trying to own. A naive value screen in India is mostly a bet on PSUs and metals.
- Then the weighting. Quintile sorts are the academic default but they throw away information. A signal-weighted or optimised portfolio captures more of the spread for the same turnover, so long as you cap single-name weights.
- Optimisation is largely cost optimisation. Buffer the rebalance so names near the boundary do not churn, trade over multiple days, net the new signal against the existing book rather than liquidating, and rebalance on a schedule that matches the signal's decay. Momentum decays in weeks so it must be traded fast; value decays over years so daily rebalancing is pure cost.
- Then combine signals before trading, not after. Running separate value and momentum sleeves means you buy and sell the same name twice. Integrating the scores into one target portfolio cuts turnover materially, often by a third.
- And measure the optimisation honestly. Every knob you turn is another degree of freedom, so I would judge the final construction on out-of-sample and out-of-region performance net of realistic costs, not on the backtest Sharpe.
Where candidates lose it
Describing quintile sorts as if that were the whole job. At a firm like this the interesting content is implementation: turnover, buffering, signal integration and cost. Also, do not forget point-in-time data. A candidate who backtests on restated fundamentals has produced a number that cannot be traded.
Expect next
- How much would costs eat from a monthly rebalanced momentum factor?
- How do you decide the rebalancing frequency?
- How do you avoid overfitting when you have tuned this many parameters?
Reported by candidates at AQR Capital Management (Investment Research, New York, 2021). Source: Wall Street Oasis.
011Factors decay after publication. How do you decide whether a factor is still investable?Quantitative asset managementFactor investing
Say this
Separate three explanations for weak recent performance: it was never real, it was real and has been arbitraged, or it is real and simply cheap right now. The test is whether the economic mechanism still exists and whether the spread has widened or narrowed.
Then walk it
- First, the base rate. Published anomaly returns fall by something like half after publication in McLean and Pontiff's work, and part of that decay is just the original result being overfitted.
- Was it ever real? Check whether it replicates out of sample, in other regions, and with sensible construction choices. If the premium only exists in US small caps before 1990 with one specific definition, it was a data artefact.
- Has it been arbitraged? Look at the money in it and at the crowding: assets in the strategy, the correlation of factor returns with flows, and whether the short leg has become expensive to borrow. Arbitrage shows up as lower premium and higher correlation across implementations.
- Or is it just cheap? This is the crucial distinction. The value spread, the valuation gap between the cheap and expensive legs, was at extreme wides in 2020 and value then delivered strongly for three years. Poor past returns with a wide spread is a buying condition, not evidence of decay.
- Then the mechanism test. A premium that is compensation for a risk or that exists because of a structural constraint on other investors, like leverage limits or benchmark-relative mandates, is much more durable than one with only a behavioural story.
- The practical conclusion: I would keep the small number of factors with strong priors, value, momentum, quality, low risk, carry, size them modestly, and refuse to time them aggressively, because factor timing on valuation spreads has a poor live record even though it looks good in backtests.
Where candidates lose it
Treating recent underperformance as proof of decay. The single most valuable distinction here is between a factor that is dead and a factor that is cheap, and the evidence for that is the valuation spread between the legs. Candidates who cannot make that distinction would have sold value in 2020.
Expect next
- Would you time factors on their valuation spread?
- How would you measure crowding?
- How many factors would you actually run?
012You regress a fund's returns on factors and the OLS assumptions are violated. How would you fix it?AQR Capital ManagementInvestments · Greenwich · 2022
Say this
Diagnose which assumption broke, because the fix differs. Heteroskedasticity and autocorrelation do not bias the coefficients, only the standard errors, so you correct the errors. Omitted variables and endogeneity bias the coefficients themselves, and that needs a change of specification.
Then walk it
- Heteroskedasticity, which is guaranteed in financial returns because volatility clusters: keep OLS coefficients and use White or Newey-West robust standard errors. Or model the variance directly with GARCH if you care about the conditional risk.
- Autocorrelated residuals, common when the fund holds illiquid or stale-priced assets: Newey-West with a sensible lag, and separately run the Dimson or Scholes-Williams correction with lagged market returns, because stale marks understate beta. Summing the lagged betas is often the real finding.
- Multicollinearity between factors, for example value and profitability after 2015: coefficients stay unbiased but become unstable and standard errors blow up. Orthogonalise the factors, drop one, or use ridge rather than pretending the loadings are precise.
- Omitted variable, which is the dangerous one: a fund with apparent alpha against a three factor model often loses all of it against a five factor model with momentum. That is bias, not inefficiency, so the fix is a better specification, not better standard errors.
- Non-normal residuals and fat tails: OLS is still consistent, but inference on short samples is unreliable, so I would bootstrap the confidence intervals rather than trusting t-statistics from 36 monthly observations.
- And the structural one nobody tests for: parameter instability. A fund's betas shift with regime, so I would run rolling windows or a Kalman filter rather than assuming one constant loading over ten years. A single full-sample regression on a manager who changed style is a meaningless number.
Where candidates lose it
Reaching straight for robust standard errors as a universal fix. Robust errors do nothing about omitted variables or endogeneity, which is where the real inference error lives in fund regressions. Separate 'the coefficient is wrong' from 'the standard error is wrong' out loud, and mention stale pricing if the fund holds anything illiquid.
Expect next
- How would you detect stale pricing in a fund's returns?
- What would you do with only 36 monthly observations?
- How do you test whether the betas are stable?
Reported by candidates at AQR Capital Management (Investments, Greenwich, 2022). Source: Wall Street Oasis.
013A manager has beaten the index for five years, but the returns load heavily on momentum. What do you do?Multi-manager allocationFund selection
Say this
You do not fire them for having a factor tilt, you reprice them. If the excess return is momentum beta, you can buy that exposure for maybe 25 basis points, so the question becomes what is left after the factor and whether the fee is justified by that residual.
Then walk it
- Quantify it first. Run the fund on market, size, value, momentum and quality, and split the excess return into factor contribution and intercept. If 80 percent of the 3 percent excess is momentum loading, the true alpha is 60 basis points before fees.
- Compare that to the replication cost. A momentum ETF or a swap on the factor costs a fraction of an active fee. If the manager charges 90 basis points for 60 of residual, the client is paying for beta that is available cheaply.
- Then ask whether the loading is intentional. A manager who says 'we buy businesses with improving fundamentals and yes, that looks like momentum' is coherent. One who claims pure bottom-up stock picking while the regression says otherwise has a process-outcome mismatch, which is the actual red flag.
- Then check the portfolio context. If I already hold two momentum-heavy managers, this one is redundant regardless of its standalone quality. Correlation of active returns across managers is what determines whether the roster adds anything.
- Then the risk question. Momentum has periodic violent crashes, 2009 being the classic, so a portfolio unknowingly stacked on it has a fat left tail that will not appear in the trailing five year statistics.
- My action: renegotiate the fee or the mandate, hedge the factor centrally if I want the residual, and if neither is possible, replace the position with the cheap factor and spend the saved fee budget on a manager whose alpha is not replicable.
Where candidates lose it
Answering either 'great track record, allocate' or 'it is just factor beta, fire them'. Neither is a decision. The professional answer prices the replicable part, tests whether the exposure is intentional, and checks redundancy against the existing roster.
Expect next
- How would you hedge the momentum exposure?
- What if the manager says momentum is their stated process?
- How long a record would you need to be confident in the residual?
Firm tags come from public, anonymous candidate reports on Wall Street Oasis: strong signal, not sworn testimony. Firms are named as the places a question was reported, not as partners of Fin Maverick. Answers are written for this page to show how to think out loud; they are not scripts to recite.

